Bioprocessing 101: Cells to proteins, operations to processes, control to quality by Lye, Gary
BIOPROCESSING 101: 
CELLS TO PROTEINS, OPERATIONS TO PROCESSES, CONTROL TO QUALITY 
 




Key Words: Expression systems, products, bioreactor design, downstream processing, quality 
 
This presentation will provide an initial introduction for delegates attending the pre-conference workshop on 
Basics of Biotechnology [1, 2]. It is designed primarily for those from physical science and traditional 
engineering backgrounds wishing to gain a rapid overview of biological products and methods for their 
manufacture. It will also be useful for life scientists wanting to gain insights into the design, monitoring and 
control of bioprocess unit operations and whole process sequences. This information will be presented in the 
context of the required product quality characteristics and their relationship to regulatory requirements. 
 
The first part of the presentation will focus on different types of protein-based products, e.g. therapeutic 
enzymes, vaccines and antibodies, their basic structure and analytical techniques for their characterization. It 
will then discuss the features of different expression systems, such as microbial and mammalian cells, their 
growth requirements and suitability for producing different types of protein product. 
 
Fermentation or cell culture is at the heart of any biomanufacturing processes. This part of the talk will give an 
overview of fermentation and cell culture process development focusing initially on growth media design and 
optimization. It will then discuss key features of traditional stirred bioreactors and how their operation impacts on 
cell growth and product formation. Bioreactor monitoring and control will also be addressed with particular 
emphasis on the types of probe conventionally used for monitoring culture conditions such as pH, temperature 
and dissolved gasses (O2 and CO2). 
 
The final part of the presentation will give an overview of the different stages of downstream processing from 
primary product recovery to purification. It will outline the key unit operations used at each stage (centrifugation, 
filtration, chromatography) and their role in removing key product and process related impurities and 
contaminants. It will also address the synthesis of typical downstream process sequences in relation to meeting 
economic and regulatory requirements such as cost and purity. 
 
This presentation is designed to lay the foundations for the following talks focused on the manufacture of 
antibody and cell therapy products. These will address the specific features and therapeutic applications of 
these key product classes and their industrial manufacture. These subsequent talks will also address the drivers 
and challenges associated with the introduction of single-use bioprocess technologies for their manufacture. 
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